This trial will study the safety of giving the Tetanus Diptheria Vaccine or Polio Boost Immunization to patients with metastatic melanoma who are already receiving immune checkpoint inhibitor therapy.
2 Primary · 1 Secondary · Reporting Duration: informed consent through date of vaccine (est apx 4-5 months)
Experimental Treatment
25 Total Participants · 2 Treatment Groups
Primary Treatment: Tetanus Diptheria Vaccine · No Placebo Group · Phase 1
Age 18+ · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: